Brolucizumab (Intravitreal Injection)
Brolucizumab is a medicine given as an injection into the eye to treat certain serious retina conditions like wet age-related macular degeneration and diabetic macular oedema. Drug class Anti-VEGF Biologic Type Single Forms Intravitreal Injection Common strength 6 mg / 0.05 mL Common Indian brands Pagenax (Beovu) Prescription status Prescription (hospital use) What Brolucizumab is
